A Virtual Reality in Practice View: Decreasing Cardiovascular Risk for Patients with Persistent Hypercholesterolemia

View Activity

FACULTY

Christie M Ballantyne, MD
Vice Chair of Research, Medicine
Professor of Medicine, Molecular and Human Genetics
Professor of Medicine, Molecular Physiology and Biophysics
Baylor College of Medicine
Director, The Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory
Co-Director, Lipid Metabolism and Atherosclerosis Clinic
Houston Methodist Hospital
Houston, TX

Michael Davidson, MD
Professor, Director of the Lipid Clinic
The University of Chicago
Pritzker School of Medicine
Chicago, IL

PROGRAM OVERVIEW

This case-based simulcast will cover the treatment and management of patients with cardiovascular disease due to hypercholesterolemia.

TARGET AUDIENCE

This activity is intended for lipidologists, cardiologists, endocrinologists, and other healthcare professionals involved in the management of patients at high risk for cardiovascular disease (CVD) due to hypercholesterolemia.

LEARNING OBJECTIVES

Upon completion of the CME activity, learners should be better able to:

  • Discuss how lowering LDL-C levels can reduce CVD risk in patients with persistently elevated cholesterol levels
  • Review clinical trial data on nonstatin LDL-C–lowering agents in patients with persistently elevated LDL-C levels and evidence regarding their positioning in treatment regimens
  • Describe best practices for identifying and managing patients with persistently elevated LDL-C levels and at high risk for CVD

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent for their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the treatment and management of patients with cardiovascular disease.

CNE Credits:
1.5 ANCC Contact Hour(s)

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Ballantyne has contracted research for Abbott Diagnostics, Akcea Therapeutics, Amarin Pharma Inc., Amgen, Esperion, Novartis, Regeneron, Roche Diagnostics, Sanofi-Synthelabo, and NIH.

Dr. Ballantyne has received consulting fees from Abbott Diagnostics, Akcea, Amarin Pharma Inc., Amgen, AstraZeneca, Boehringer Ingelheim, Denka Seiken, Esperion, Intercept Pharmaceuticals, Inc., Janssen, Matinas Biopharma Inc., Merck, Novartis, Novo Nordisk, Regeneron, Roche Diagnostics, and Sanofi Synthelabo.

Dr. Davidson has received consulting fees and is on the speakers bureaus of Amgen, Novo Nordisk, Sanofi Regeneron and Genzyme Corporation.

CME Content Review
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP Educational Development for Med Learning Group has nothing to disclose.
Melissa Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: June 14, 2019

EXPIRATION DATE: June 14, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.